These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

412 related articles for article (PubMed ID: 22747870)

  • 21. Osteomalacia in a patient with Paget's bone disease treated with long-term etidronate.
    Hoppé E; Masson C; Laffitte A; Chappard D; Audran M
    Morphologie; 2012 Aug; 96(313):40-3. PubMed ID: 23022200
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Dynamic radionuclide study in Paget's disease before and after (Asu1,7) E-calcitonin treatment.
    Vattimo A; Martini G
    J Nucl Med Allied Sci; 1984; 28(3):217-20. PubMed ID: 6241632
    [No Abstract]   [Full Text] [Related]  

  • 23. Monostotic Paget's disease of the tibia in Korea.
    Lee CH; Han SH; Yoon BY; Lee YW
    Clin Rheumatol; 2004 Aug; 23(4):381-2. PubMed ID: 15293109
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Active Paget's disease of bone with normal biomarkers of bone metabolism: a case report and review of the literature.
    Gkouva L; Andrikoula M; Kontogeorgakos V; Papachristou DJ; Tsatsoulis A
    Clin Rheumatol; 2011 Jan; 30(1):139-44. PubMed ID: 20886248
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Paget's disease of the tibia.
    Wang CL; Wu CT; Chien CR; Hang YH
    J Formos Med Assoc; 1999 Jun; 98(6):444-7. PubMed ID: 10443070
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Evaluation by using radionuclide uptake of bone in Paget's disease of bone: special reference to treatment with calcitonin.
    Dokoh S; Fukunaga M; Yamamoto I; Torizuka K; Morita R
    Radioisotopes; 1988 Jun; 37(6):339-42. PubMed ID: 3212230
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Bone scintigraphy in evaluation of Didronel therapy for Paget's disease.
    Lee JY
    Clin Nucl Med; 1981 Aug; 6(8):356-8. PubMed ID: 6455232
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Bone turnover markers in Paget's disease of the bone: A Systematic review and meta-analysis.
    Al Nofal AA; Altayar O; BenKhadra K; Qasim Agha OQ; Asi N; Nabhan M; Prokop LJ; Tebben P; Murad MH
    Osteoporos Int; 2015 Jul; 26(7):1875-91. PubMed ID: 26037791
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Quantitative evaluation of bone scintigraphy in the assessment of Paget's disease activity.
    Pons F; Alvarez L; Peris P; Guañabens N; Vidal-Sicart S; Monegal A; Pavía J; Ballesta AM; Muños-Gómez J; Herranz R
    Nucl Med Commun; 1999 Jun; 20(6):525-8. PubMed ID: 10451864
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Paget's disease of the ulna: a rare location.
    Infante JR; González FM; Gonzalez J; Pacheco C; Vallejo JA; Torres M; Latre JM
    Clin Nucl Med; 2001 Jul; 26(7):634-5. PubMed ID: 11416751
    [No Abstract]   [Full Text] [Related]  

  • 31. Osteosarcoma arising in Paget's disease of the calvarium.
    Mehta RC; Wilson MA; Perlman SB
    J Nucl Med; 1988 Mar; 29(3):414-6. PubMed ID: 3162256
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Persistent effect of zoledronic acid in Paget's disease.
    Tziomalos K; Florentin M; Krikis N; Perifanis V; Karagiannis A; Harsoulis F
    Clin Exp Rheumatol; 2007; 25(3):464-6. PubMed ID: 17631747
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The "black beard" sign of monostotic Paget's disease of the mandible.
    Mailander JC
    Clin Nucl Med; 1986 May; 11(5):325-7. PubMed ID: 3698429
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Whole body retention of Tc-99m phosphate in Paget's disease of bone.
    Hadjipavlou A; Lisbona R; Garbuz D; Abibtbol JJ
    Clin Nucl Med; 1991 Jun; 16(6):435-8. PubMed ID: 1868658
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Paget's disease. A cause of artificially elevated bone mineral density.
    Balseiro J; Eggli DF; Ziessman HA
    Clin Nucl Med; 1987 Oct; 12(10):809-10. PubMed ID: 3677525
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Treatment of Paget's disease of bone (osteitis deformans) with sodium etidronate (EHDP).
    Rashid M; Khairi A; Johnston C
    Clin Orthop Relat Res; 1977; (127):94-105. PubMed ID: 410576
    [No Abstract]   [Full Text] [Related]  

  • 37. Comparative study of alendronate versus etidronate for the treatment of Paget's disease of bone.
    Siris E; Weinstein RS; Altman R; Conte JM; Favus M; Lombardi A; Lyles K; McIlwain H; Murphy WA; Reda C; Rude R; Seton M; Tiegs R; Thompson D; Tucci JR; Yates AJ; Zimering M
    J Clin Endocrinol Metab; 1996 Mar; 81(3):961-7. PubMed ID: 8772558
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effective Treatment of Paget's Disease of the Bone in a Chinese Woman.
    Kuthiah N; Er C
    Ann Acad Med Singap; 2018 Dec; 47(12):528-530. PubMed ID: 30636270
    [No Abstract]   [Full Text] [Related]  

  • 39. The diphosphonate space: a useful quantitative index of disease activity in patients undergoing hydroxy methylene diphosphonate (HMDP) bone imaging for Paget's disease [corrected].
    Evans A; Perkins A; Wastie M; Stone M; Hosking D
    Eur J Nucl Med; 1991; 18(9):757-9. PubMed ID: 1809266
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Ivory fingers: monostotic Paget's disease of the phalanges.
    Calif E; Vlodavsky E; Stahl S
    J Clin Endocrinol Metab; 2007 May; 92(5):1590-1. PubMed ID: 17483373
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.